Integra LifeSciences | IART - مصاريف البيع والإدارة

سعر السهم
10.41
التغيير اليومي
-0.33 -3.07%
شهريا
14.14%
سنويا
-40.00%
Q2 التوقعات
10.34




مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.27B 138M 2026-03
AtriCure USD 78.34M 109K 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.78B 53M 2026-03
CONMED USD 166.76M 26.42M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
HeartBeam USD 1.18M 96.62K 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Orthofix International USD 130.35M 11.31M 2025-12
Smith & Nephew USD 1.42B 65M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03